Lenti-D demonstrates the ability to stabilize neurologic disease progression in phase II/III study Sep. 23, 2019
Rottapharm Biotech presents CR-13626, an oral tyrosine kinase inhibitor for the treatment of GBM Sep. 23, 2019
FDA approves Pifeltro and Delstrigo for virologically suppressed adults with HIV-1 infection Sep. 23, 2019
RSS